Starpharma (ASX:SPL) is an Australian biopharmaceutical company developing novel therapeutics and improving existing pharmaceuticals using its proprietary dendrimer technology. Starpharma's portfolio includes multiple clinical-stage oncology products which use its DEP (Dendrimer Enhanced Product) drug delivery technology, and marketed products including Viraleze and VivaGel. Starpharma has multiple DEP partnerships with international biopharmaceutical companies, including AstraZeneca, MSD, and Chase Sun.